CCR5 and cancer: CCL3 derived from TAMs and cancer cells in esophageal squamous cell carcinoma (ESCC) promoted tumor cell migration and invasion via the CCL3-CCR5 axis and the PI3K/Akt and MEK/ERK pathways [351].